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OBJECTIVE — We have reported that renal hyperﬁltration is associated with endothelial
dysfunctioninearlytype1diabetes.However,therelationshipbetweenrenalhyperﬁltrationand
arterial stiffness is unknown. Accordingly, we measured arterial stiffness in type 1 diabetic
subjects with hyperﬁltering (n  20) or normoﬁltering (n  18).
RESEARCH DESIGN AND METHODS — Augmentation index (AIx), aortic pulse
wavevelocity(PWV),renalhemodynamicfunction(inulinandparaaminohippurateclearances),
and urinary and circulating plasma cGMP were measured in normoalbuminuric subjects with
type 1 diabetes during clamped euglycemia (glucose 4–6 mmol/l) and hyperglycemia (glucose
9–11 mmol/l).
RESULTS — During clamped euglycemia, hyperﬁltering subjects (glomerular ﬁltration rate
135ml/min/1.73m
2)exhibitedlowerAIxvalues(6.12.9vs.13.92.7%,P0.001)and
higher cGMP levels in urine and plasma compared with normoﬁltering subjects. These differ-
ences were maintained during clamped hyperglycemia. As expected, renal hemodynamic re-
sponses to clamped hyperglycemia were exaggerated in normoﬁlterers, but values for AIx
remained unchanged.
CONCLUSIONS — Renal hyperﬁltration is associated with reduced arterial stiffness in sub-
jects with uncomplicated type 1 diabetes.
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E
arlytype1diabetesisassociatedwith
renal hemodynamic function
changes characterized by arteriolar
vasodilation and hyperﬁltration (1). In
addition to renal microvascular vasodila-
tion, previous work has suggested the
presence of macrovascular arterial dys-
function in diabetic subjects with renal
hyperﬁltration, which may reﬂect gener-
alized endothelial dysfunction (2). In ad-
dition to effects on endothelial function,
diabetes is associated with increased arte-
rialstiffness,whichiscorrelatedwithpro-
gression of diabetic nephropathy and
increased systemic vascular risk (3–7).
Therelationshipbetweenarterialstiffness
andrenalhyperﬁltration,whichistheear-
liest preclinical manifestation of diabetic
renal microvascular dysfunction, is cur-
rently unknown.
Accordingly, we studied arterial stiff-
ness in subjects based on renal ﬁltration
statustofurtherelucidatetherelationship
between early renal and systemic abnor-
malities in diabetes (3,8). We hypothe-
sizedthatarterialstiffnesswouldbelower
in hyperﬁltering subjects (glomerular ﬁl-
trationrate[GFR]135ml/min/1.73m
2)
than in individuals with normoﬁltration
(GFR 135 ml/min/1.73 m
2). Further-
more, we hypothesized that hyperﬁlter-
ingsubjectswouldexhibithigherlevelsof
vasodilators.
RESEARCH DESIGN AND
METHODS— Augmentation index
(AIx), pulse wave velocity (PWV), and re-
nal hemodynamic parameters were mea-
sured during euglycemia (4–6 mmol/l)
and hyperglycemia (9–11 mmol/l) on 2
consecutive days for6hb yam odiﬁed
clamp technique (8,9). In the left arm, a
peripheral venous cannula was inserted
for infusion of glucose and insulin, and a
second cannula was inserted for blood
sampling more distally.
Peripheral blood pressure was ﬁrst
measured in the brachial artery with an
automated DINAMAP sphygmomanome-
ter (Critikon, Tampa, FL). Right radial ar-
tery waveforms were recorded with a
high-ﬁdelity micromanometer (SPC-301;
Millar Instruments, Houston, TX), and
using the validated transfer function, cor-
responding central aortic pressure wave-
forms were generated (SphygmoCor,
Sydney, Australia). AIx and aortic PWV
were measured as described previously
(10). Data were analyzed by a single ob-
server (D.Z.I.C.) who was blinded to the
glycemic day, renal hemodynamic mea-
surements, and ﬁltration status.
After the arterial stiffness studies, a
third intravenous line was then inserted
into the right arm and connected to a sy-
ringe infusion pump to measure renal
hemodynamic function (8,9,11). Inulin-
and paraaminohippurate-derived mea-
sures of GFR and effective renal plasma
ﬂow were taken. Circulating renin-
angiotensin system mediators, urine and
plasma cGMP, and insulin levels were
also measured (8,11).
Data were analyzed on the basis of
renal ﬁltration status (online appendix A,
availableathttp://care.diabetesjournals.org/
cgi/content/full/dc10-0767/DC1) (2,8,9).
Based on previous work examining the ef-
fect of clamped hyperglycemia on arterial
stiffnessanda10%standarddeviation(12),
ourstudyhada80%powertodetect10%
differences in arterial stiffness at the 0.05
level of signiﬁcance. Between-group base-
line comparisons were made using para-
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group and within-group differences in all
hemodynamicparametersweredetermined
by repeated-measures ANOVA (SPSS, ver-
sion 14.0).
The University Health Network and
HospitalforSickChildren(Toronto,Can-
ada)ResearchEthicsBoardsapprovedthe
protocols, and patients gave informed
consent.
RESULTS— Clinical parameters in
the two groups were similar at baseline
(online appendix B). AIx was lower in hy-
perﬁltering versus normoﬁltering sub-
jects during clamped euglycemia; values
for PWV were similar in the two groups
(Table 1). Urinary and plasma cGMP,
GFR,andﬁltrationfractionwerehigherin
hyperﬁltering subjects; plasma aldoste-
rone, angiotensin II, insulin levels, effec-
tive renal plasma ﬂow, renal blood ﬂow,
and renal vascular resistance were similar
in the two groups.
During clamped hyperglycemia,
between-group differences in cGMP and
AIx remained signiﬁcant (Table 1). There
were no observed within-group differ-
ences in AIx or PWV, but as expected,
clamped hyperglycemia was associated
with increases in GFR and ﬁltration frac-
tion in normoﬁltering subjects.
CONCLUSIONS— Early type 1 dia-
betes is commonly accompanied by renal
hyperﬁltration. Although renal hyperﬁl-
tration is related to the eventual develop-
ment of clinical diabetic nephropathy in
someindividuals,theriskofnephropathy
is also affected by a number of other fac-
tors including differences in blood pres-
sure or glycemic control, and age at
diagnosis (13). Previous work has de-
scribed differences in the regulation of
the renal and, more recently, the systemic
circulation in hyperﬁltering versus nor-
moﬁltering subjects (2,8). To our knowl-
edge, this is the ﬁrst time that arterial
stiffness has been measured in type 1 di-
abetic subjects who were analyzed on the
basis of renal ﬁltration status. Our ﬁrst
major observation was that AIx was lower
in hyperﬁltering subjects, while aortic
PWV was similar. This suggests that AIx
reﬂectingsmallerperipheralresistancear-
terystiffnesssegregatesbasedonﬁltration
status, whereas aortic PWV reﬂecting
largercentralconduitarterystiffnessdoes
not. Higher urinary and plasma cGMP
levels support the concept of increased
nitric oxide bioactivity in hyperﬁltering
subjects with uncomplicated type 1 dia-
betes, leading to generalized vasodilation
and decreased peripheral and renal vas-
cular resistance with an elevated GFR.
We used a hyperglycemic clamp tar-
get of 9–11 mmol/l to avoid an osmotic
diuresis and renin angiotensin system
activation and have previously observed
exaggerated renal responses to hypergly-
cemia in normoﬁltering subjects (8). In
the current study, the renal response to
hyperglycemia was not accompanied by
changes in AIx. In contrast, Gordin et al.
(12) reported that under higher 15 mmol/l
hyperglycemic conditions, AIx increases.
Taken together, this suggests that renal
hemodynamicfunctionmaybemoresen-
sitive to acute changes in blood glucose
levels compared with arterial stiffness,
where changes may depend on longer-
term glycemic control (14).
This study has important limitations.
Weattemptedtolimittheeffectofsample
size by studying a homogeneous cohort.
Giventhenarrowageofsubjects,theﬁnd-
ings cannot be generalized to older indi-
viduals with diabetes.
Inconclusion,renalhyperﬁltrationin
uncomplicated type 1 diabetes is associ-
ated with lower values for arterial stiff-
ness, suggesting that hyperﬁltration
identiﬁes a group of subjects with gener-
alized changes in vascular function.
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Table1—Arterialstiffness,bloodpressure,andrenalhemodynamicfunctionresponsesduring
clamped euglycemia and hyperglycemia in hyperﬁltering and normoﬁltering subjects with
uncomplicated type 1 diabetes
Hyperﬁltering group
(n  20)
Normoﬁltering group
(n  18)
Euglycemia Hyperglycemia Euglycemia Hyperglycemia
Circulating factors
Urine cGMP (pmol/l) 957  326 426  101 287  79* 126  50†
Plasma cGMP (pmol/l) 4.8  0.7 4.9  0.5 2.7  0.5* 2.6  0.3†
Angiotensin II (pg/ml) 5.4  2.0 3.3  0.8 3.3  0.7 3.3  0.9
Aldosterone (pmol/l) 167  45 166  33 109  18 130  32
Plasma insulin (pmol/l) 129  40 125  42 118  36 113  35
Systemic hemodynamic
function
AIx (%) 6.1  2.9 5.3  3.5 11.5  2.6* 10.2  2.3†
Aortic PWV (m/s) 6.85  0.22 6.87  0.19 6.90  0.26 6.82  0.30
Systolic blood pressure
(mmHg) 117  10 115  10 113  8 115  10
Diastolic blood pressure
(mmHg) 65  86 3  56 1  56 1  4
Mean arterial pressure
(mmHg) 80  97 9  67 5  67 6  5
Heart rate (bpm) 71  12 71  13 69  15 70  13
Renal hemodynamic
function
Effective renal plasma
ﬂow (ml/min/1.73 m
2) 693  70 733  94 670  70 701  79
GFR (ml/min/1.73 m
2) 144  3 149  7 120  3* 137  6‡
Filtration fraction 0.20  0.03 0.20  0.03 0.18  0.01* 0.20  0.01‡
RBF (ml/min/1.73 m
2) 1,147  28 1,210  39 1,081  40 1,125  39
RVR (mmHg/l/min) 0.068  0.004 0.066  0.003 0.070  0.004 0.069  0.003
Data are means  SD. AIx, radial augmentation index corrected to an average heart rate of 75 bpm; aortic
PWV, carotid-femoral pulse wave velocity RBF, renal blood ﬂow (effective renal plasma ﬂow/1  hemat-
ocrit); RVR, renal vascular resistance, derived by dividing the mean arterial pressure by RBF. Filtration
fraction is determined by dividing the GFR by the effective renal plasma ﬂow. *P  0.001 in hyperﬁltering
vs. normoﬁltering subjects during clamped euglycemia. †P  0.048 in hyperﬁltering vs. normoﬁltering
subjects during clamped hyperglycemia. ‡P  0.025 for the within-group effect of clamped hyperglycemia.
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